A Phase IIb Randomized, Double-Blind, Placebo-Controlled, Multi-Centre, Dose Ranging Study of Atuliflapon in Participants with Proteinuric CKD: FR-PO979

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2023-11, Vol.34 (11S), p.677-678
Main Authors: Heerspink, Hiddo J., Ufnal, Marcin, Law, C Gordon, Whatling, Carl A., Ericsson, Hans I., Knöchel, Jane, Connolly, Kathleen, Kinch, Russell J., MacPhee, Iain
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1046-6673
DOI:10.1681/ASN.20233411S1677c